Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium continuation therapy following electroconvulsive therapy.

A Coppen, M T Abou-Saleh, P Milln

    The British Journal of Psychiatry : the Journal of Mental Science
    |October 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PERIPHERAL SEROTONERGIC AND ADRENERGIC RESPONSES IN DEPRESSION.

    Acta psychiatrica Scandinavica·2017
    Same author

    TRACE AMINE DEFICIT IN DEPRESSIVE ILLNESS: THE PHENYLALANINE CONNEXION.

    Acta psychiatrica Scandinavica·2017
    Same author

    Chairman's introduction.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Chairman's summary.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Backache.

    Lancet (London, England)·2010
    Same author

    Osteochondritis Juvenilis of the Lower Ulna Epiphysis.

    Proceedings of the Royal Society of Medicine·2009
    Same journal

    Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    Definitional invisibility: when institutional language reframes identity as choice.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    Potential implications of removing evidence of impairment from the DSM-5 age-of-onset criterion in adult ADHD assessment.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    The pressurised leaky funnel: rethinking recruitment, selection and retention in the UK psychiatry workforce.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    Cutting through stigma: psychiatry and neurosurgery working together.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    A fourth pillar for evidence-based medicine: implications for psychiatry - CORRIGENDUM.

    The British journal of psychiatry : the journal of mental science·2026
    See all related articles

    Lithium therapy significantly reduces depressive relapse rates in patients treated with electroconvulsive therapy (ECT). This study highlights the importance of continuation therapy post-ECT to prevent recurring episodes of depression.

    Area of Science:

    • Psychiatry
    • Clinical Neuroscience
    • Pharmacology

    Background:

    • Electroconvulsive therapy (ECT) is an effective acute treatment for severe depression.
    • Relapse rates after ECT are notably high, indicating a need for effective continuation strategies.

    Purpose of the Study:

    • To evaluate the efficacy of lithium as a continuation therapy in preventing depressive relapse after successful ECT.
    • To compare relapse rates between patients receiving lithium and those receiving a placebo post-ECT.

    Main Methods:

    • A double-blind, randomized trial involving 38 patients recovering from depression treated with ECT.
    • Patients were assigned to receive either lithium or placebo for one year post-recovery.
    • Duration of depressive episodes during the follow-up year was recorded.

    Related Experiment Videos

    Main Results:

    • Patients on placebo experienced an average of 7.8 weeks of depressive episodes during the year.
    • Patients receiving lithium had significantly fewer depressive episodes, averaging only 1.7 weeks (P < 0.02).
    • Lithium treatment markedly reduced morbidity associated with depressive relapse.

    Conclusions:

    • Continuation therapy, specifically with lithium, considerably reduces relapse rates following ECT.
    • ECT alone is insufficient as a long-term treatment for depressive illness; continuation therapy is essential.
    • Lithium demonstrates significant prophylactic effects against depressive relapse after ECT.